Related Experiment Videos
Neurophysiological alterations following fluvalinate administration in mice
1Department of Pharmacology, College of Veterinary Sciences, Haryana Agricultural University, Hisar, India.
Indian Journal of Experimental Biology
|April 1, 1992
Summary
The median lethal dose of fluvalinate was determined in mice, revealing dose-dependent effects on the nervous system. Fluvalinate exposure led to seizures, reduced pain response, and altered anesthesia duration, indicating neurotoxic potential.
Area of Science:
- Toxicology
- Neuropharmacology
- Pesticide Research
Background:
- Fluvalinate is a pyrethroid pesticide used for pest control.
- Understanding its toxicological profile is crucial for risk assessment.
Purpose of the Study:
- To determine the median lethal dose (LD50) of fluvalinate in albino mice.
- To investigate the neurotoxic effects and dose-dependent responses of fluvalinate.
Main Methods:
- Median lethal dose (LD50) determination via intraperitoneal (ip) injection in albino mice.
- Observation of gross behavioral signs and assessment of neurological functions (seizures, analgesia, anesthesia).
- Evaluation of acute and subacute (7-day) treatment effects on pentobarbitone-induced sleeping time and combined toxicity with phenobarbitone.
Main Results:
- The median lethal dose (LD50) of fluvalinate was established at 105 mg/kg (ip) in albino mice.
- Observed signs included dose-dependent central and peripheral nervous system stimulation.
- Fluvalinate administration induced maximal electroshock seizures, shortened reaction time in analgesic tests, and prolonged ether anesthesia duration.
- Both acute and subacute fluvalinate treatments increased pentobarbitone sleeping time.
- Pre-treatment with phenobarbitone enhanced the toxicity of fluvalinate.
Conclusions:
- Fluvalinate exhibits significant neurotoxic effects in mice, primarily acting as a nervous system stimulant.
- The LD50 and observed neuropharmacological effects highlight the potential hazards associated with fluvalinate exposure.
- Combined exposure with other CNS-active agents like phenobarbitone may exacerbate fluvalinate toxicity.